ClearPoint Neuro (CLPT) 8-K MRI Interventions Announces Closing of $7.522 Million Private Placement

Exhibit 99.2

MRI INTERVENTIONS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(UNAUDITED)

	March 31, 2019			Pro Forma Adjustments			Pro Forma March 31, 2019
ASSETS
Current Assets:
Cash and cash equivalents	$	2,491,670		$	7,522,011	(1)	$	10,013,681
Accounts receivable		1,266,797						1,266,797
Inventory, net		2,024,935						2,024,935
Operating lease rights of use, current portion		98,668						98,668
Prepaid expenses and other current assets		199,576						199,576
Total current assets		6,081,646			7,522,011			13,603,657
Property and equipment, net		498,783						498,783
Software license inventory		679,400						679,400
Operating lease rights of use		355,176						355,176
Other assets		10,639						10,639
Total assets	$	7,625,644		$	7,522,011		$	15,147,655
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	502,986		$	100,000	(2)	$	602,986
Accrued compensation		667,768						667,768
Operating lease liabilities, current portion		104,127						104,127
Other accrued liabilities		319,654						319,654
Deferred revenue		679,485						679,485
Total current liabilities		2,274,020			100,000			2,374,020
Accrued interest		892,125						892,125
2014 junior secured notes payable, net		1,944,871						1,944,871
Operating lease liabilities		367,061						367,061
2010 junior secured notes payable, net		1,704,948						1,704,948
Total liabilities		7,183,025			100,000			7,283,025
Commitments and contingencies
Stockholders’ equity:
Preferred stock		—
Common stock		110,672			24,265	(1)		134,937
Additional paid-in capital		108,752,502			7,397,746	(1)(2)		116,150,248
Accumulated deficit		(108,420,555	)					(108,420,555	)
Total stockholders’ equity		442,619			7,422,011			7,864,630
Total liabilities and stockholders’ equity	$	7,625,644		$	7,522,011		$	15,147,655

⁽¹⁾ Reflects the receipt of proceeds of $7,522,011 in the Financing Transaction.

⁽²⁾ Reflects the costs, estimated to be $100,000, to be incurred in connection with the Financing Transaction.